A Danish court has granted a preliminary injunction against Nomeco A/S, a pharmaceutical wholesaler in Denmark, prohibiting the sale of a generic version of Pfizer’s Lipitor by Ranbaxy. The injunction, issued by the Copenhagen City Court in Denmark and subject to appeal by Nomeco, requires Ranbaxy’s generic atorvastatin product to be withdrawn from the Danish market pending the outcome of a patent infringement trial that has not yet been scheduled. The court ruled in Pfizer&#821...